BONNIE SPELLMAN: Open Payments
NPI 1902689011 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 49 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $138 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $334 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $190 |
| Vanda Pharmaceuticals Inc. | 3 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $28 |
| Abbott Laboratories | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, FANAPT, UBRELVY, Kerendia, JARDIANCE, Auvelity, QULIPTA.
Industry payments across LA — which companies pay providers there.
